Combining COVID-19 vaccine data from claims with data from immunization information systems (IIS) to address exposure misclassification: An approach within the FDA biologics effectiveness and safety (BEST) initiative

Bell, E.; Zhou, C.; Schneider, K. L.; Lloyd, P.; Clarke, T.; Yang, G.; Wilkinson, M.; Amend, K.; Myers, E.; Anderson, S.; Shoaibi, A.; Seeger, J.; Wong, H. L.

Bell, E.; Zhou, C.; Schneider, K. L.; Lloyd, P.; Clarke, T.; Yang, G.; Wilkinson, M.; Amend, K.; Myers, E.; Anderson, S.; Shoaibi, A.; Seeger, J.; Wong, H. L..

Pharmacoepidemiology and Drug Safety ; 31:604-605, 2022.

Article in English | Web of Science | ID: covidwho-2083429

Search on Google

XML

Collection: Databases of international organizations Database: Web of Science Type of study: Experimental Studies Topics: Vaccines Language: English Journal: Pharmacoepidemiology and Drug Safety Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

XML